Blu Venture Investors — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Strados Labs builds wearable biosensors and a cloud platform that continuously capture and analyze respiratory data — including cough, spirometry, FeNO, and eCOA endpoints — in patients' daily lives.
AI & Machine LearningBiotechDigital HealthMedical DevicesPhiladelphia, US
Nick Delmonico(CEO & Co-founder)Yu Kan Au(Clinician Co-founder)Richard Powers(Executive Officer, Director)Steve Bishop(Director)Robert Ball(Director)Alex Levit(Director)
Co-investorsBand of AngelsBrincBroad Street AngelsCathexis VenturesNeer Venture PartnersNextFab Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.